ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[PDGFRB, RRM1, SFRP1, CSDE1, RNF38, H3F3A, KIT, SOX8, MEA1]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[USP8, EIF4A3, RAB35, RAPGEF1, CIB1, BPTF]
GO:0002480;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;7.57984905034425;0.0011128243517809471;0.710754145523778;[HLA-C, LNPEP, HLA-A, HLA-F]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[ITGB1, CD40, RNH1, BTG1, ROCK2, PDCD6, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, RRAS, TBXA2R, ABL1, CTSH, GTF2I, CCR2, MAP3K3, STARD13, XBP1, JUP, TNFRSF12A, SPHK1, SERPINF1, SARS, RHOB, PDCL3, SFRP1, IL6, SP1, TEK, EPHA1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, CD40, SPHK1, TRADD, ITGB2, CIB1, NLRC4, AGER, NFKB1, RELA, MTDH, RPS6KA4, RPS6KA5, TRIM14, NLRP3, RIPK1, KRAS, TRIM32, CARD11]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[ITGB1, MAP3K3, XBP1, CD40, BTG1, JUP, SPHK1, PDCD6, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, RHOB, C3, PDCL3, RRAS, SP1, TBXA2R, ABL1, CTSH, TEK, EPHA1]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[VAMP8, HLA-C, ITGAV, HLA-A, HLA-F, TAPBP]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[MAP3K3, MAP3K1, TAOK2, RAPGEF1]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[UPF2, UPF1, RPS9, SMG1, RPL3, RPS7, EIF4A3, RPL23A, PPP2R2A, CASC3, SMG5, PPP2CA, RPS15, DHX34, SKIV2L, ETF1, DCP1A, RPL29, DCP2, RPL19]
GO:0030705;cytoskeleton-dependent intracellular transport;5.0;0.5960880403619941;0.5882850320419173;7.885554947433499;33.20429938101479;4.695669262696007;0.0011113180183532213;0.5303777563261461;[WASL, TRAK1, FNBP1L, RAB21, FXR1, AP3M1, ARHGAP21, TUBA1C, CLN3, TUBA1B, RHOT2, SPAST, RHOT1, KIF3B, KIF13B, RAB6A, TNPO1, SPG11, IFT122, KIF23, WDR34, DYNLL2, CCDC88B, CCDC88A, KIF4A, CLUAP1, PAFAH1B1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, SFRP1, KARS, IL23A, RFX4, HOXB4, PAXIP1, NOLC1, HSPH1, RAD21, HLTF, SCAP, HOXC4, ZBED1, ZNF143, CREBBP, XBP1, XRCC6, JUP, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SETX, STAG1, CDKN1C, ARF4, CD40, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, NIPBL, ING2, HRAS, TEAD2, ZNF485, SEC13, NCOA6, SIRT7, TMEM173, PPRC1, SIRT2, GNL3, GAL, MTF2, TFEC, MAPRE3, ZNF350, HEATR1, GPS2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, PLAGL2, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, MIXL1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, UBE3A, PARK7, YY1, EP300, ZNF564, PIAS2, ARMCX3, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, BCL2L12, MED30, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CIITA, BMPR2, ONECUT2, CHD8, DDX41, LDB2, PKD2, CKS1B, FLCN, LBH, SIN3A, NUP62, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, ZNF516, EAPP, MET, HDAC3, HDAC1, WBP2, CEBPG, TP53INP2, TP53INP1, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, ARID3B, USF2, CD4, KLF6, TNIP2, ASXL2, TAF7, TAF4]
GO:0071377;cellular response to glucagon stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;6.558197802812269;0.015486127626965131;0.7103865406232063;[ADCY4]
GO:0070966;nuclear-transcribed mRNA catabolic process, no-go decay;10.0;1.0;0.9152410118609203;9.628524252492122;717.2549128915896;8.67846133901236;0.0240058764469685;0.8590579283277371;[CNOT6, CSDE1]
GO:0032446;protein modification by small protein conjugation;8.0;0.657518819034173;0.7037594095170865;8.790195062087678;151.8478999048328;3.234601667173665;0.005082212555577183;0.5404176796836216;[PPP1R11, CCNF, UBE3A, BRCA1, UBE2Z, UBE2L3, SENP6, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, SUMO3, CDC26, TRIM24, TRIM69, SKP2, C18orf25, CDK5RAP3, RNF44, FBXO18, DTX3L, ARRDC1, NSMCE2, ATG10, ZFP91, SENP2, TRPC4AP, PIAS2, RC3H2, RNF40, DDB1, KCTD10, MED20, ANAPC5, BIRC6, THOP1, CBLL1, RNF166, HIST1H2BC, ANAPC13, HIST1H2BO, PCNA, HIST1H2BJ, CDCA3, MGRN1, RNF38, MYCBP2, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, FZR1, RNF213, RAB40C, MED30, RNF138, UBD, HLTF, UBR5, ZBED1, RFFL, RNF20, UBE2I, UBE2B, KLHL25, CBX4, FEM1B, BCL11A, SYVN1, FBXL15, LNPEP, FBXL16, KLHL24, MARCH6, MARCH3, MIB1, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, RFWD3, ASB8, TSPAN17, KBTBD2, CDC16, FBXL3, TRIM32, ASB3, KBTBD8, TRIM33]
GO:0051403;stress-activated MAPK cascade;10.0;0.811012628672052;0.8207473261969463;9.451593544333043;288.8226961090722;5.500407508664414;0.009666635715219814;0.696532107649126;[PTGER4, MAP4K2, TNIP2, GPS1, TAOK2, GPS2, CCM2, NFKB1, MAPK13]
GO:0030148;sphingolipid biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;8.992535485772125;238.8284648682076;5.288437257948329;0.007993373787475071;0.6213702925661609;[ELOVL5, SPHK2, AGK, SPHK1, ELOVL6, SGPP2, ALDH3A2, P2RX7, UGT8, SGPL1, VAPA, DEGS1, CSNK1G2]
GO:0006171;cAMP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;6128.1106202320725;7.292166977892469;0.20510234751766956;0.8053507106995271;[ADORA2A, ADCY4]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[SLC1A4, HTR3B, GLS, ALS2, SYPL1, CDK5, ADORA2A, PNOC, VDAC3, MBP, NPTX1, SNCB, APBA3, SPG11, KCNK3, NTSR1, PAFAH1B1]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[BCR, PDGFRB, SGPL1, ABL1, RAPGEF1]
GO:0045773;positive regulation of axon extension;11.0;0.8933024483968273;0.8790801765280758;9.582004236857228;1257.908905926367;6.113511981550823;0.04210107903683872;0.7450742393735527;[BMPR2, TNFRSF12A, RUFY3, ADNP, RAB11A, PAFAH1B1]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[RTKN, ROCK2, ARHGAP1, MYO9B, RHOC, RHOB, RHOT2, RHOT1, COL1A2, ARHGDIB, CFL1, TAX1BP3, ARHGEF1]
GO:0042147;retrograde transport, endosome to Golgi;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;84.48667651462847;5.311165509025885;0.0028276930298722367;0.5947335637161829;[TMEM87A, VPS29, GOSR1, ZFYVE21, VPS26B, BAIAP3, VPS52, CLTCL1, STX5, VPS54, ANKFY1, TBC1D23, RAB6A, PLEKHJ1]
GO:0045662;negative regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;6.518977089658987;0.0038363580074348307;0.6565011041187423;[SOX8, CXCL14]
GO:0097411;hypoxia-inducible factor-1alpha signaling pathway;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;8.390779266560578;7.75488093814194E-4;0.7193458537639684;[PDK1]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[DDX17, OLFM1, PDCD6, NOLC1, KLHL12, SPRY1, FAM83D, KBTBD8]
GO:0034058;endosomal vesicle fusion;7.0;1.0;0.8509193652572005;9.628524252492122;65.8060249050737;7.474488534686424;0.0022024684319953925;0.7331650565203278;[VPS41, VPS8, VPS11, ANKFY1]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[RAB3B, SYS1, RPL3, NUP107, RTKN, NCF1, BUB1B, ZDHHC6, ABCA12, IPO4, RPS15, IPO8, IPO9, LAMP2, LONP2, GSTK1, RPS9, RPS7, COG3, PAQR3, TOMM34, ARMCX3, NUP93, RAB35, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, SEH1L, AGER, FBLN5, NCKIPSD, UGT8, BAG4, RAD21, SSR1, RAB6A, FAM83D, S100A10, BBS2, TOR1A, PMM1, JUP, XRCC5, CAV1, RCC2, RAB3IP, PMM2, IFT122, NUP153, TIMM44, UBAC2, CDK5, GOLGB1, DCP1A, CD24, EZH2, ARF4, TRAM1, PIGU, ITGB2, SRP54, WASL, PTPRK, TRAM2, GPHN, SEC61A2, NIPBL, SIN3A, NUP62, TMEM107, TMED2, TNPO1, TNPO2, ARL5A, RAB8B, GRIPAP1, SEC13, FCER1G, SSR2, SEPT2, GAK, ACOX2, RER1, AGPS, EXOC3, PIK3C3, MAPRE3, MAPRE1, VAMP5, EXOC1, MCPH1, BECN1, TOMM40, ROCK2, ZDHHC23, HSD17B4, ZDHHC24, RGPD1, TM9SF4, AP3M1, WRN, RAB40C, PES1, LMNA, HEATR3, BID, RAE1, RPL19, PEX16, TIMM8B, UBL4A, SEPT11, TMEM30A, PEX19, ANGPT1, AGK, RPL23A, RAB11A, TM9SF1, SPCS2, VAPA, SLMAP, VPS41, TSPAN17, RAB13, TAOK2, RAB3GAP2, RAB3GAP1]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[FLCN, PDCD6, RAPGEF1, CIB1, TRIB3, MTM1]
GO:0097191;extrinsic apoptotic signaling pathway;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;51.05903939735586;5.277263957350204;0.0017089000984773794;0.5929998367869052;[SIVA1, TNFRSF12A, DIABLO, EYA2, PARP2, CD70, TRADD, G0S2, TNFRSF10B, CIB1, TNFRSF10A, P2RX7, BAG3, CASP3, MKNK2, CASP2, RIPK1, IL12A, ITGAV, BID, APPL1]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[CDKN1C, TOP2B, BTG2, CDKN1A, CCNK, BTG1, ZWILCH, CCNF, GMNN, BUB1B, BRCA1, PTPRK, PKD2, GPR132, RPS6KA2, MYC, CASP3, ZNF207, CASP2, EP300, IL12A, KNTC1, FBXO5, TOPBP1, GTSE1, HRAS, CDK5RAP3, DACT1, TIPIN, PRKAB1, RHOB, ERN1, TFDP1, RBL1, ESPL1, TFDP2, CTDSP2, TIMELESS, PRR11, MCPH1, PCNA, TP53I13, MAX, XPC, THBS1, PPM1G, CCNB1, FZR1, RAD21, TPR, TP53INP1, TP53BP2, ABL1, RBBP7, E2F7, E2F8, FANCI, ZBTB17, PRNP, CDKN2C, INTS3, DONSON, MAD2L1BP, CNOT10, CDC7, ZWINT, CDK9, CNOT4, CNOT6, CENPF, WEE1, STAG2, RAD51, CDK6, CNOT7, FAP, CDK5, CNOT1, RHEB, RFWD3, CNOT3, TAOK2, CDK2, INTS7, CNOT8, EIF4G2, EZH2, MAD2L1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, CD40, SLC20A1, TRADD, RELA, MTDH, AKAP13, TFG, UBD, NUP62, ABL1, RIPK1, CCL19, ECT2, TMED4, MAP3K3, UBE2I, ZDHHC13, TNFRSF10B, RHOC, CD4, VAPA, TNIP2, TRIM32, CARD11]
GO:0045664;regulation of neuron differentiation;7.0;0.5064924996362321;0.6041656150753165;7.722354432086322;62.256296269576055;3.3619766685088743;0.0020836622091136505;0.5228510084326481;[BMPR2, GFI1, CIB1, CYB5D2, EIF4ENIF1, CFL1, KIF13B, SOX8, SCARF1, CDK5RAP3, ZNF365, SEMA6B, ACTR2, TNFRSF12A, SERPINF1, PAQR3, OMG, THOC2, NME1, GAK, OLFM1, SFRP1, RUFY3, RAPGEF1, ADNP, FKBP4, PAFAH1B1, FOXG1, TRAK1, LRP8, RAB21, FXR1, NCKIPSD, ABL1, DVL3, LRIG2, ECT2, MARK2, TMEM30A, SEMA4D, SSH3, RAB11A, MIB1, SETX, CCDC88A, CDK5, FES, CAPRIN1, CAMK1, TRIM32, EZH2]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, RNF113A, PABPN1, RAVER1, PCF11, U2AF2, POLR2B, POLR2E, DHX16, SNRPB2, POLR2G, SMNDC1, DCPS, SF3B1, RBM5, SPEN, DDX17, AQR, PRPF38A, RBM15, GPKOW, BUD31, CPSF3, NONO, CPSF2, TFIP11, CWC15, LSM5, SRRM1, PRPF4, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7, SF1]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[CCDC88B, CD40, IL4R, IRF4, CLEC7A, BCL3, IL12A, LYST, HRAS]
GO:0042953;lipoprotein transport;8.0;1.0;0.875;9.628524252492122;68.44752614357394;7.138016298065211;0.0022908771012512216;0.7400384854347593;[MIA3]
GO:0031338;regulation of vesicle fusion;6.0;0.7248374789738407;0.6855390520770648;8.935377071932177;48.20117096329211;5.514393750639154;0.0016132498139038735;0.6051266654433651;[VPS18, RABGAP1, TBC1D8, TBC1D2B, TBC1D3C, CORO1A, TRIM9, VPS41, VPS11, RUNDC1, EVI5L, TBC1D22A, TBC1D15, VPS16]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[ITGB1, FCER1G, ITGB4, ITGB3, ITGA2, RCC2, ITGB2, NEDD9, ITGAE, VAV1, FUT8, ABL1, CCM2, ITGAV]
GO:0048268;clathrin coat assembly;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;44.51706700895919;6.781341354126479;0.0014899461700306506;0.6699184248047958;[CLTCL1, AP2S1, CLTA]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[USP8, SEPT11, PDCD6IP, RTKN, KIF23, RHOC, SEPT2, CIT, RHOB, SPAST, SON, ESPL1, KIF4A, CFL1, RAB35, JTB, CHMP4B, KIF20A, ECT2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[ITGB1, CXCL6, CIITA, CDKN1A, CD40, CD80, TRADD, ITGB2, IL5RA, CIB1, RORA, IL27, RPS6KA4, RPS6KA5, MYC, CASP3, CFL1, IL12A, CCR2, HLA-DPA1, IFNAR2, IL4R, TNFRSF12A, FLT3LG, HLA-C, HLA-A, HLA-F, YWHAZ, VAV1, KARS, IL23A, IRF4, KIT, RAPGEF1, PSME2, LCP1, HLA-DQB1, EBI3, LRP8, ADIPOR2, RELA, IL22RA2, HSP90B1, RAP1B, BAG4, CCL5, IL21R, NCAM1, RIPK1, CCL19, IL12RB1, HLA-DQA1, CCR10, BBS2, MAP3K3, CCL20, CD70, MX2, TNFRSF10B, TNFRSF10A, NFKB1, NFKBIA, CD4, IL6, KLF6, COL1A2, TNIP2, HLA-DPB1, SDC1, KRAS, HLA-DRB3, LIMS1]
GO:0003429;growth plate cartilage chondrocyte morphogenesis;8.0;1.0;0.875;9.628524252492122;76.28302296905001;6.8867018697843045;0.002553124128510584;0.7271862538851576;[COL7A1]
GO:0010510;regulation of acetyl-CoA biosynthetic process from pyruvate;8.0;1.0;0.875;9.628524252492122;198.41229450693845;7.697632086000634;0.0066406809376752364;0.7686572628545723;[PDPR, PDK1]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[CTSK, LCP1, A2M]
GO:2000272;negative regulation of signaling receptor activity;7.0;0.7248374789738407;0.7133381047441208;8.965230035081857;205.5464783691117;6.343086423195323;0.006879455651193543;0.6753050999230941;[ERRFI1, CLEC12B, CHMP6, AGER]
GO:0009303;rRNA transcription;11.0;0.8436909121759173;0.8542744084176208;9.510741216835738;822.3157603842984;6.8867018697843045;0.027522168463925335;0.7846152062148197;[GTF3C1, MARS, SIRT7]
GO:0006396;RNA processing;7.0;0.49247393176386933;0.5971563311391352;7.484544189674715;115.0816327851482;3.0330144413691222;0.0038516786825735262;0.5060278648384131;[AHCYL1, CCNH, POP4, EIF4A3, CASC3, RRP9, EFTUD2, RPS15, ALKBH5, RAVER1, ARL6IP4, SNIP1, ZNF326, SEPHS1, DDX17, AQR, RPS9, MBNL1, RPS7, PUS1, SSU72, SARS, IMP4, THOC2, SRRM1, THOC6, ERN1, PRPF4, KARS, PSPC1, PRPF3, RPL7L1, MRTO4, SNRPG, RPP21, CD2BP2, SF1, ISG20L2, NOLC1, SUPT6H, OSGEP, DHX30, DHX34, CPSF6, PRPF38A, INTS3, CPSF3, NONO, CPSF2, CWC15, LSM5, PUM2, SETX, PAN3, SON, LAS1L, INTS4, INTS7, INTS6, MNAT1, GRSF1, INTS8, SUV39H1, INTS10, DDX42, NAT10, DDX41, USP39, WDR43, RBM3, UBL5, PTBP1, ZC3H7A, PCF11, C1QBP, DHX16, RBM5, WDR37, RBM15, BUD31, PAPD4, TFIP11, FASTKD5, SLU7, RBMS2, TRUB2, SF3B5, SF3B2, DDX27, POLDIP3, WBP4, DDX23, HEATR1, PPP2CA, RNF113A, PABPN1, U2AF2, POLR2B, PES1, POLR2E, SAP18, SNRPB2, POLR2G, EXOSC3, SMNDC1, DCPS, SF3B1, SPEN, GPKOW, WTAP, WDR18, ADAT1, TRMT1, GTF2H4, BYSL, BOP1, ACIN1]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[VPS18, DTX3L, MGRN1, VPS33A, VPS4B, CLEC16A, TRAK1, LYST, MTM1, RHOB, VPS41, VPS11, VPS16]
GO:0009306;protein secretion;8.0;0.5696777571895439;0.659838878594772;7.923776160253697;130.2874189859313;4.786641040901733;0.004360602662394617;0.6197890454332871;[RAB3B, SUCNR1, FGG, MIA3, NLRC4, BTN3A2, PARK7, GAL, SNX19, GPAM, NLRP3, LCP2, ITGAV, CCL19, CARD11, PAFAH1B1, RAB8B]
GO:0002476;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;5.0;0.8653626801206646;0.7229223519212526;9.405380701177911;42.20009821028515;7.697632086000634;0.0014123993094755708;0.6838982747154925;[HLA-C, HLA-A, HLA-F]
GO:0030238;male sex determination;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.564882071422225;7.138016298065211;7.217571957966554E-4;0.6150384854347593;[SF1]
GO:2001238;positive regulation of extrinsic apoptotic signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.54514264355307;358.11284317915005;5.8650506222523235;0.011985714580571521;0.6961795867550195;[CYLD, SFRP1, TNFRSF12A, CAV1, G0S2, RIPK1, BID, STK4, THBS1, STK3]
GO:0070972;protein localization to endoplasmic reticulum;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;32.77360880529348;5.014899692882714;0.001096903192380182;0.5795825161008517;[RPS9, RPL3, PMM1, RPS7, PMM2, SRP54, RPL23A, UBAC2, RPS15, SEC61A2, SPCS2, VAPA, CHMP4B, RAB3GAP2, RPL29, RAB3GAP1, RPL19]
GO:0001819;positive regulation of cytokine production;5.0;0.5089359064165209;0.5447089650691808;6.969264215559344;44.25546033084785;3.8109268885567773;0.001481190429944989;0.48513199016793795;[CD40, CD80, ZBTB20, RORA, PTPN22, IL27, DDX41, BRCA1, PARK7, EP300, IL12A, LRRFIP1, HRAS, CCR2, HLA-DPA1, HAVCR2, IL4R, FCER1G, ARNT, TMEM173, KARS, IL23A, IRF4, TLR7, TBC1D23, CARD11, ANKRD17, PTGER4, EBI3, CEBPG, THBS1, AGER, RELA, C3, NLRP7, NLRP2, ABL1, NLRP3, MBP, RIPK1, CCL19, IL12RB1, ARFGEF2, CREBBP, XBP1, XRCC6, CADM1, CCL20, XRCC5, GLMN, EIF2AK3, NFKB1, PUM2, MAPK13, P2RX7, CCDC88B, CD4, NLRP12, IL6, POLR3B, POLR3C, BCL3, HLA-DPB1, TRIM32, LSM14A, CD244]
GO:0032897;negative regulation of viral transcription;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;62.48948681665221;6.641579411751319;0.0020914668868664225;0.6905700452391912;[HDAC1, CCL5, TRIM14, TRIM32]
GO:0042572;retinol metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;118.00963323224862;6.375876246018314;0.003949676222508656;0.722303232910233;[RDH11, RDH5]
GO:0035082;axoneme assembly;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;53.25370651110567;6.481236761676141;0.0017823536317024158;0.6823701146576509;[BBS2, SPAG16, UBE2B, TTLL3, IQCG]
GO:0003374;dynamin family protein polymerization involved in mitochondrial fission;8.0;1.0;0.875;9.628524252492122;46.126504921393284;7.57984905034425;0.0015438126085597365;0.7626338329336335;[MX2]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, VPS29, AHCYL1, RPL3, NUP107, NCF1, PDCD6, ZDHHC6, TBC1D3C, IPO4, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, RPS9, RPS7, COG3, AP1B1, TOMM34, TBC1D2B, MYO7A, SYTL3, BCR, NUP93, RAB35, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, COPB2, COPA, VPS26B, HSP90B1, NCKIPSD, CLTCL1, VPS11, SSR1, RAB6A, TBC1D15, VPS16, AP1M1, PMM1, RAB3IP, PMM2, NUP153, RAB27B, TIMM44, NFKBIA, POLA2, PAN3, NPLOC4, CDK5, BCL3, HYOU1, CD24, ARF3, ARF4, TRAM1, YWHAB, SRP54, CLTA, SEC61A2, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TMED7, TNPO2, ARL5A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, TBC1D8, RHOB, ACOX2, AGPS, SLU7, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, RAB40C, LMNA, AP2S1, HEATR3, STX5, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, AGK, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, VPS45, SEC24C]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[FRMPD3, ABCA12, RPH3A, PSMD7, PSMD2, LAMP2, FAM3C, RNASE3, SCAMP1, UNC13D, SYTL3, ACLY, SLC27A2, KPNB1, UBR4, IQGAP2, CORO1A, C3, RAP1B, COMMD9, NCKAP1L, A2M, RAB6A, AP1M1, XRCC6, JUP, XRCC5, BRPF3, HSPA6, SURF4, RAB27B, NFKB1, COPS5, CDK5, DEGS1, MAN2B1, CALM1, SERPINA3, PYGB, GPI, SIGLEC9, WDR1, ITGB3, ITGB2, MIA3, PIK3CG, TRIM9, HK3, ACTR1B, SCRN1, PHACTR2, CTSH, SDF4, ITGAV, GUSB, SNAP29, FGA, ACTR2, SERPINB1, FCER1G, FGG, PLAUR, COMMD3, TMEM173, SERPINB6, VAMP8, KIT, EXOC3, ALDOC, VAMP4, DOCK2, ALDOA, VAMP5, EXOC1, CSTB, PDXK, CLEC12A, THBS1, STX11, CLEC3B, CCL5, PSMB1, CDC37L1, ARFGEF2, TMEM30A, SYT15, LILRB3, RAB11A, P2RX7, SNX19, FABP5, VAPA, IMPDH2, VPS41, RAB18, CD9, PTX3, MNDA]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ITGB1, ERRFI1, CD40, DOCK8, ARHGAP1, TBC1D3C, DOCK11, RGS1, ARHGDIB, EVI5L, TBC1D22A, HRAS, SEC13, TBC1D8, TBC1D2B, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, DEPDC1, RAPGEF1, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RABGAP1, RASGRP2, RIC8A, ABR, ARHGAP21, CCL5, DVL3, NCKAP1L, CCL19, ECT2, A2M, TBC1D15, S100A10, STARD13, SEMA4D, CCL20, RCC2, MYO9B, ARHGAP25, GNAQ, RUNDC1, RAB3GAP2, SMAP1, RAB3GAP1, EZH2, LIMS1]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[PDGFRB, HSD3B7, CXCL6, FCER1G, CCL20, ITGB2, LYST, CORO1A, CXCL14, VAV1, PIK3CG, IL6, CCL5, RAB13, KIT, NCKAP1L, CCL19, ARHGEF5, CCR10, CCR2, HBEGF]
GO:0006516;glycoprotein catabolic process;6.0;0.811012628672052;0.7286266269261705;9.414950152194063;376.2457910508191;7.069023426578259;0.012592608027242692;0.6846304993685643;[MGEA5, EDEM1, SGSH]
GO:0006517;protein deglycosylation;7.0;0.7671156992804218;0.7344772148974115;9.326243380619188;247.8243933626011;6.311337724880743;0.008294459418372403;0.6736814700148209;[MGEA5, RNF103, MAN2B2, EDEM1, SYVN1, DERL2, MAN2B1, MAN1B1, PARK7, MARCH6]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[ZNF516]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[FANCI, RNF20, PAXIP1, ANGPT1, WFS1, SPHK1, CAV1, PDCD6, PTPN22, UBE3A, BRCA1, COMMD1, SENP2, MASTL, RNF40, UBE2L3, CDK9, FZR1, UBQLN1, TRIB3, SKP2, CDK5RAP3]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, CD40, DDX41, ZC3HAV1, LYST, RELA, NLRP3, IFNAR2, DDX17, APOBEC3F, DTX3L, APOBEC3H, MX2, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, TLR7, SERINC3, APOBEC3A, EXOC1]
GO:0032486;Rap protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;7.379178354882098;9.9090025448413E-4;0.7523715242355574;[RAP1B, RAPGEF1]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[CCNF, BUB1B, UBE3A, UBE2Z, UBE2L3, PSMD8, PSMD7, PSMD4, PSMD2, CDC26, LONP2, SKP2, C18orf25, USP8, RNF44, FBXO18, ARRDC1, TRPC4AP, KCTD5, RNF40, KCTD10, TBL1XR1, CHMP4B, ANAPC5, UBR4, ANAPC11, HSP90B1, CCNB1, RNF213, UBD, UBR5, USP51, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, ERLIN2, BTBD6, MARCH6, NSFL1C, CYLD, RNF103, NPLOC4, CDC16, FBXL3, USP36, USP37, USP38, PPP1R11, USP32, USP34, KIF14, OTUD7B, TRIM9, CTSO, CTSK, CTSH, USP46, SEC13, PDCD6IP, DTX3L, RAD23A, VPS37A, SIRT2, DDB1, PSMA1, MAN1B1, USP41, DERL3, VPS4B, RNF38, USP12, DERL2, NEDD8, PSMB10, PSMA7, ARNTL, FZR1, PSMB5, TP53INP2, PSMB1, UBQLN1, RFFL, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, KBTBD4, ITCH, SPSB1, FAP, PSMC1, TRIM32, MAD2L1]
GO:0010591;regulation of lamellipodium assembly;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;72.62159929772238;6.343086423195323;0.0024305795732986186;0.6993857346658935;[NCKAP1, BIN3, ARPC2, ATP7A, SSH3]
GO:0045616;regulation of keratinocyte differentiation;7.0;0.8259837884571596;0.7639112594857803;9.461470167828956;71.48722327515921;6.113511981550823;0.002392613028695569;0.663564652301091;[ERRFI1, ROCK2, CTSK, GRHL1, AQP3]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, AHCYL1, DGKD, DGKA, DEFB1, PIK3CG, HEBP1, AKAP13, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, SPHK2, SPHK1, RHOC, VAV1, VAV2, RHOB, SFRP1, GAL, ADORA2A, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, XPR1, PTGER4, SUCNR1, ROCK2, ADCY4, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, CCL5, CCL19, ECT2, NTSR1, CCR10, SULT1A3, SLC12A2, CCL20, CAV1, GPR55, TSHR, BAIAP3, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, CALM1, CALM2]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[CMTM7, ITGB1, DCLRE1C, CEBPG, GPS2, DOCK11, KLF6, SP3, BCL3, KIT, ABL1, EP300, CARD11]
GO:1901798;positive regulation of signal transduction by p53 class mediator;8.0;0.8259837884571596;0.7879918942285797;9.466005322994347;239.11083947336738;6.781341354126479;0.008002824611389124;0.7217981122146513;[RPS7, CDK5RAP3]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CTSH, ITGAV, GUSB, SNAP29, ACTR2, SERPINB1, FCER1G, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, ALDOC, DOCK2, ALDOA, SLC27A2, KPNB1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, C3, RAP1B, COMMD9, PSMB1, NCKAP1L, RAB6A, AP1M1, XRCC6, TMEM30A, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, VAPA, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, EBI3, PDCD1LG2, CORO1A, AGER, CCDC88B, CD4, IL6, HLA-DMB, GPAM, IL23A, CCL5, HLA-DPB1, NCKAP1L, IL12A, CCL19, IL12RB1, CD24, CARD11, CCR2, HLA-DPA1, HAVCR2]
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.249034630787218;56.871035456649615;5.192106149009898;0.0019034223761250782;0.6617651750982834;[PTGER4, AKAP13, GNG2, ADORA2A, TBXA2R, GNAQ, ADCY4, CRHR1, TSHR]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[ITGB1, SCARB1, DGKD, TFRC, SH3KBP1, WIPF2, ITGB3, ITGB2, STON1, CLTA, UBE3A, WASL, FNBP1L, RABEPK, PIK3CG, KIAA1109, ANKFY1, ITGAV, SCARF1, HRAS, FCER1G, FNBP1, UNC13D, NME1, RUFY1, GAK, ADORA2A, PIK3C3, DOCK2, MET, CSNK1G2, CSNK1G1, COLEC12, CD163L1, LRP8, CORO1A, AGER, TM9SF4, HSP90B1, CLN3, HSPH1, CLTCL1, AP2S1, APOL1, AMBP, CAV1, CDC7, MARCH3, MIB1, EHD4, SYNJ1, CDK5, SNX17, CD9, HYOU1]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, ITGB1, SCARB1, CD163L1, TFRC, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, AGER, HSP90B1, CLN3, HSPH1, CLTCL1, AP2S1, APOL1, SCARF1, FCER1G, AMBP, CAV1, GAK, SYNJ1, SNX17, CD9, HYOU1]
GO:0000422;autophagy of mitochondrion;6.0;0.8653626801206646;0.7558016526504768;9.446202695698167;99.5332381578633;6.015873511986907;0.003331287907044985;0.6307723637598831;[BECN1, GABARAPL1, FUNDC1, CTSK, MARK2, ATG5]
GO:0046822;regulation of nucleocytoplasmic transport;6.0;0.6547035408479693;0.6504720830141292;8.529911963824013;30.746838917960506;5.040875179285974;0.0010290690282256237;0.5809109036834981;[CDKN1A, HDAC3, CPSF6, ANGPT1, JUP, MX2, NOLC1, NUP153, THOC2, PARK7, TMEM173, SUPT6H, PPP1CC, CDK5, BAG3, PKIA, TPR, NUP62, XPO5, UBR5, CAMK1, ECT2, GTSE1, EMD]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC2, TRAPPC3, SEC13, TRAPPC2L, PDCD6, KLHL12, PPP6C, TFG, TBC1D20, TRAPPC6B, COL7A1, TMED2, STX5, SEC24C]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, ARF4, COPA, DCTN4, PDCD6, GOSR1, DCTN3, KLHL12, TEX261, MIA3, RAB43, SPAST, TFG, TMED2, STX5, TMED1, TMED7, TMED4, TRAPPC2, TRAPPC3, TMED9, TRAPPC2L, COG4, COG3, DDHD2, COG1, DYNLL2, SPTB, ARFGAP1, YIF1A, ARCN1, TBC1D20, TMEM115, VAPA, TRAPPC6B, GOLGB1, COL7A1, HYOU1, SEC24C, SEC22C]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[NFKBIA, CD40, BAG4, KARS, TNFRSF12A, CD70, TRADD, TNFRSF10B, RIPK1, TNFRSF10A, RELA, LIMS1]
GO:0010906;regulation of glucose metabolic process;7.0;0.6763753087927167;0.6891070196535589;8.753055515138222;59.50955823828417;5.171903441692378;0.00199173135911005;0.615410747783455;[IGFBP5, RORA, PDK1]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[ITGB1, KIF14, ARHGAP1, RASGRP4, ABR, FLCN, ARHGAP21, AKAP13, RHOT2, RHOT1, PSD4, NUP62, ARHGDIB, ABL1, ECT2, A2M, HRAS, PDGFRB, ARFGEF2, STARD13, GPR55, MYO9B, RHOC, ARHGAP25, VAV1, VAV2, RHOB, BCR, ITPKB, DEPDC1B, ALS2, MADD, RAPGEF1, KRAS, ARHGEF1, SPRY1, MET, ARHGEF5]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[RAP1B, IGFBP5, RAPGEF1, ITPR2, PKD2, PIK3CG, AQP1]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[COL7A1, ITGB2, ITGAV, MIXL1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ITGB1, ERRFI1, CXCL6, GPI, COPA, GMFB, NCF1, EBI3, CLEC12B, IL27, PARK7, AGER, CXCL14, CCL5, NPPA, IL12A, FAM3C, CCL19, CMTM7, UBE2I, CCL20, CD70, BUD31, FLT3LG, NETO2, KLHL24, IL6, GAL, CDK5, IL23A, PNOC, SCGB3A1, CHMP6, KCNK3, HBEGF]
GO:0033327;Leydig cell differentiation;4.0;1.0;0.75;9.628524252492122;40.68519770516384;7.379178354882098;0.0013616969528911006;0.6273715242355574;[SGPL1, SF1]
GO:0071569;protein ufmylation;9.0;0.8933024483968273;0.8428918493787028;9.571365838652174;153.79381005389072;7.9853141584524145;0.005147340417060716;0.8046099625986299;[CDK5RAP3]
GO:2001014;regulation of skeletal muscle cell differentiation;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;72.04683906309076;6.832634648514029;0.002411342865496127;0.7244212536750128;[TBX1, DDX17, ARNTL]
GO:0010586;miRNA metabolic process;8.0;0.8653626801206646;0.8076813400603323;9.456673995565463;117.72069011476309;6.943860283624253;0.003940005556398338;0.7301093378270707;[DDX17, XPO5]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[TBCCD1, WDR1, SEMA4D, EPB41, SH3KBP1, WIPF2, LST1, ITGB2, CDC7, VRK1, VRK2, WASL, RHOC, CORO1A, RHOB, VIL1, MKLN1, CFDP1, FES, TAOK2, KIT, ALDOA, CSNK1G2, CSNK1G1]
GO:0006182;cGMP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;6128.1106202320725;6.558197802812269;0.20510234751766956;0.7678154929528684;[NPPA, ADCY4, AQP1]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[RABGAP1, RCC2, TBC1D8, RUNDC1, TAX1BP3, TBC1D2B, TBC1D3C, EVI5L, ECT2, EPHA1, TBC1D22A, TBC1D15]
GO:1903507;negative regulation of nucleic acid-templated transcription;9.0;0.5547065974044363;0.6735939238825073;8.375761283996754;898.5514994986271;2.646975117554892;0.030073710044371104;0.5316070557889775;[TCERG1, ZNF175, NAB1, GFI1, GMNN, ARID4A, UBP1, ZBTB20, IKZF1, IKZF2, YY1, RPS6KA5, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, SFMBT2, ZBTB32, SARS, ZNF12, HCFC2, RUNX2, THAP1, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, SF1, ZNF274, MAX, FOXG1, MEPCE, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, CBX4, XRCC5, WFS1, BCL11A, NONO, CAV1, H3F3A, NFXL1, NFKB1, CNOT7, CDK5, QARS, YEATS2, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, RCOR3, ZNF136, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, TCF25, SUV39H1, CHD8, OTUD7B, BRCA1, LDB2, PTPRK, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, ZNF485, TSC22D4, HELLS, KLF11, HBZ, KLF12, PEG3, RFC1, SIRT7, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, TFDP2, NFX1, MTF2, TFEC, DEPDC1, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, ARNTL, BCLAF1, RXRA, DNAJB5, SAP18, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, TRIM33, LIMS1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[PRKCSH, SERPINA10, CCNF, MIA3, MSLN, PSMD8, PSMD7, PSMD4, PSMD2, SKP2, FGA, IGFBP5, ESCO1, FGG, COMMD1, RABGGTA, DDB1, PSMA1, PSME2, ITIH2, GPS1, COPS7B, NEDD8, COPS7A, PSMB10, PSMA7, HSP90B1, C3, TGOLN2, PSMB5, RBBP5, UBD, PSMB1, RBBP7, APOL1, ATG5, KLHL25, WFS1, FEM1B, RHBDD1, FBXL15, FBXL16, BTBD6, RAB11A, IL6, SPSB1, COPS5, PSMC1, ASB8, RAB13, STT3A, CALU, FBXL3, ASB3, KBTBD8]
GO:0006983;ER overload response;6.0;0.8653626801206646;0.7558016526504768;9.434368238051164;81.5596405220072;7.379178354882098;0.002729727769360572;0.7004918368257019;[WFS1, EIF2AK3, ATG10]
GO:0006620;posttranslational protein targeting to endoplasmic reticulum membrane;11.0;1.0;0.9324289523296623;9.628524252492122;336.65241395888097;7.57984905034425;0.011267453327701498;0.8200627852632958;[SEC61A2, CHMP4B]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNK, CDKN2C, CCNH, CCNF, PKMYT1, PKD2, CDC25A, CKS1B, CCNB1, CDK6, CCNE2, CCNE1, CASP3, MAPRE3, MNAT1, CDK5RAP3, CCNJL]
GO:0006616;SRP-dependent cotranslational protein targeting to membrane, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;169.63248762716802;7.57984905034425;0.005677446701553932;0.8028748447945538;[SEC61A2, SRP54]
GO:0050771;negative regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;885.0968544383536;5.54296712308321;0.029623395182598163;0.6987086083097278;[SEMA6B, CDK5, SEMA4D, RUFY3, OMG]
GO:0006613;cotranslational protein targeting to membrane;11.0;0.9326813400603323;0.8987696223598284;9.584072489921288;151.34345246524913;5.223196736079928;0.005065329153747539;0.6995434763162781;[RPS15, TRAM1, RPS9, RPL3, RPS7, SSR2, SRP54, SSR1, RPL23A, RPL29, RPL19]
GO:0045199;maintenance of epithelial cell apical/basal polarity;6.0;1.0;0.8231203125901445;9.628524252492122;34.60247581110787;7.138016298065211;0.001158113725191344;0.6881587980249038;[PDCD6IP, WDR1, LRCH4]
GO:0030968;endoplasmic reticulum unfolded protein response;5.0;0.8653626801206646;0.7229223519212526;9.387362195675234;54.36536464462378;5.142344639450834;0.0018195598290039001;0.5532207558659172;[ZBTB17, XBP1, WFS1, EDEM1, DERL3, SYVN1, EIF2AK3, DERL2, EIF2S1, ARFGAP1, YIF1A, HSP90B1, ERN1, CREB3, EXTL2, TBL2, CTDSP2, LMNA, DNAJB11, SSR1, TPP1, HYOU1, SULT1A3, CDK5RAP3]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[CDKN1A, XRCC6, XRCC5, ELK1, TANK, RHOB, RAD51AP1, NIPBL, SFRP1, WRN, RAD51, POLE3, INTS7, ECT2, HRAS]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CREBBP, CDKN1A, PCNA, RHBDD1, XPC, PTPRK, EIF2S1, CDC25A, AQP1, MAPK13, YY1, DDB1, HIST3H2A, MYC, TP53INP1, PBK, EP300, PPID]
GO:2000178;negative regulation of neural precursor cell proliferation;6.0;0.7980440201809971;0.722142322680643;9.117698628726131;64.43316573945785;6.781341354126479;0.002156520071215264;0.6699184248047958;[BTG2, RAPGEF1, SIRT2]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IRF4, HLA-DPB1, HLA-C, NCAM1, HLA-A, HLA-DRB3, HLA-F, HLA-DQA1, HLA-DPA1, HLA-DQB1]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[CD80, PTPN22, MIA3, THBS1, CASP3, ARHGDIB, ABL1, CTLA4, MBP, HAVCR2, PRNP, LAG3, IL4R, ANGPT1, SEMA4D, SWAP70, RCC2, FGG, GLMN, PDCD1LG2, RC3H2, DUSP22, CYLD, ITCH, TWSG1, ADORA2A, CD9, FXYD5, CBLL1]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP2, NCKAP1, ARF4, DGKD, BMPR2, NCF1, ITGB3, PDCD6, ARPC1A, WASL, IGF1R, TIAL1, PTBP1, RPS6KA5, CASP3, ITGAV, HRAS, EPHB4, APPL1, PDGFRB, ACTR2, CAMLG, GFRA2, SIRT2, VAV1, VAV2, BCR, SLC9A6, CD8B, DDIT4, KIT, ELMO1, RAPGEF1, LCP2, EPHA1, MET, HBEGF, ROCK2, NEDD9, EFNA4, RASGRP4, SGPL1, POLR2B, AP2S1, ATP6V0A2, ABL1, POLR2E, POLR2G, NCKAP1L, CSK, ATP6V1F, FAM83A, ANGPT1, EIF2AK3, PILRB, PILRA, SHCBP1, SETX, VIL1, CD4, ARPC2, PTPRA, FES, TEK]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[CYFIP2, NCKAP1, VPS29, OXTR, MAML1, WIPF2, PKD2L1, TIAL1, RPS6KA4, NSDHL, RPS6KA5, GNAT2, MYC, HOMER3, IL12A, EPHB4, CSNK2A1, FLT3LG, HLA-C, HLA-A, HLA-F, RUNX2, RC3H2, BCR, SFRP1, TWSG1, KARS, IL23A, DDIT4, PSME2, EPHA1, EBI3, APCDD1, CRHR1, IL22RA2, MTDH, SGPL1, TSPAN7, TSPAN4, ATP6V0A2, NCKAP1L, TSPAN2, HLA-DQA1, CCR10, SULT1A3, BBS2, CREBBP, SIVA1, RCC2, EIF2AK3, PILRB, PILRA, SETX, CYLD, COL1A2, SDC1, CALM1, HLA-DRB3, CD24, CPEB4, ARF4, CDKN1A, CD40, SIGLEC9, ARPC1A, IL27, WASL, PTPRK, CTLA4, HRAS, CCR2, HLA-DPA1, APPL1, FCER1G, CAMLG, TNFRSF12A, PARP2, ROM1, PDCD1LG2, BTN3A2, GFRA2, SIRT2, VAV1, VAV2, DDB1, ITPKB, KIT, RAPGEF1, TAX1BP3, HBEGF, HLA-DQB1, NOTCH2NL, NEDD9, LILRA2, AKAP2, RELA, RNF138, PERP, AP2S1, CCL19, BID, IL12RB1, MAP3K3, MAP3K1, CCL20, CD70, RYK, G0S2, MYO9B, LILRB3, MIB1, ITCH, CENPJ, HLA-DPB1, LIMS1, GALNT11, SCARB1, DGKD, NCF1, CD80, PDCD6, IL5RA, CIB1, RORA, IGF1R, ADORA3, NPPA, CFL1, EP300, TLE4, IFNAR2, SEMA6B, PDGFRB, LAG3, IL4R, SLC9A6, CD8B, CCNE1, MADD, ELMO1, CSNK1G2, CARD11, CSNK1G1, CD151, DIABLO, DTX2, KLHL12, ADIPOR2, CORO1A, EFNA4, AGER, RASGRP4, HSP90B1, RAP1B, NCKIPSD, FUT8, BAG4, BAG3, BAG1, ABL1, DVL3, RIPK1, MARK2, ATP6V1F, FAM83A, EIF2B4, UBE2B, BTN2A1, IFT122, TNFRSF10B, TNFRSF10A, NFKB1, VIL1, NFKBIA, IL6, ARPC2, PTPRA, FES, GNAQ, ITGB1, CXCL6, CIITA, BMPR2, ITGB4, ITGB3, CHD8, TRADD, ITGB2, USP34, PTPN22, ITGAE, PTBP1, CLEC1A, CASP3, NUP62, CASP2, ITGAV, DACT1, ACTR2, ITGA2, PLAUR, SENP2, YWHAZ, SEPT2, DUSP22, ADORA2A, IRF4, LCP2, LCP1, DAGLB, MET, STOML2, ROCK2, CLEC12B, LRP8, CLN3, GNG2, POLR2B, CCL5, MKNK2, IL21R, POLR2E, POLR2G, NCAM1, CSK, SPEN, ANGPT1, SEMA4D, EYA2, MX2, SHCBP1, TSHR, P2RX7, CD4, KLF6, P2RX4, TNIP2, TSPAN17, CD9, CCM2, MNDA, KRAS, TEK, TNRC6A]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNAR2, IRF4, MX2, HLA-C, HLA-A, HLA-F]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP36, USP37, USP38, PPP1R11, USP32, CCNF, USP34, KIF14, BUB1B, UBE3A, UBE2Z, UBE2L3, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, USP46, USP8, SEC13, RNF44, FBXO18, DTX3L, ARRDC1, RAD23A, VPS37A, TRPC4AP, KCTD5, SIRT2, RNF40, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, USP41, DERL3, VPS4B, RNF38, USP12, UBR4, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, RNF213, PSMB5, TP53INP2, UBD, PSMB1, UBR5, UBQLN1, USP51, RFFL, RNF20, XBP1, UBE2I, LRRC29, UBE2B, KLHL25, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, MARCH6, KBTBD4, NSFL1C, CYLD, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, CDC16, FBXL3, TRIM32, MAD2L1]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, HDAC1, CAV1, CHD8, KLHL12, STK4, STK3, CYLD, SFRP1, RAPGEF1, DVL3, EMD, DACT1]
GO:0034638;phosphatidylcholine catabolic process;8.0;1.0;0.875;9.628524252492122;826.6337400402087;8.16763571524637;0.02766668735707926;0.7926932703116032;[GDPD3]
GO:2000503;positive regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1000.5321764499969;7.9853141584524145;0.03348691152528284;0.8407982897480031;[CCL5, CXCL14]
GO:0044791;positive regulation by host of viral release from host cell;9.0;1.0;0.896240625180289;9.628524252492122;253.86718028650722;8.16763571524637;0.008496706058560384;0.8139338954918922;[VAPA]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PIK3CG, PPP6C, C1QBP, HAVCR2, FGA, MAP4K2, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, TLR7, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, PPP1R14B, APOBEC3F, APOBEC3H, XRCC5, NONO, MX2, NFKB1, ANKHD1, CYLD, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[FLCN, ERRFI1, NLRP12, ABL1, RAPGEF1, CSK, SPRY1]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[CIB1, PTPN22, AGER, IGF1R, RAP1B, CCL5, ABL1, CCL19, HRAS, EPHB4, HAVCR2, PDGFRB, FGA, ANGPT1, CCL20, RYK, FGG, GPR55, CD4, KARS, KIT, RAPGEF1, TEK, EPHA1, MET]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[UPF1, CD40, ABCC2, CCL20, FGG, RORA, TANK, NFKB1, RELA, MAPK13, YY1, SFRP1, NLRP7, CCL5, CCL19]
GO:2000623;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;1.0;0.9152410118609203;9.628524252492122;1197.4866120488684;8.390779266560578;0.04007879923729291;0.8443458537639685;[DHX34, SECISBP2]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[TUBGCP2, VPS4B, CIB1, TUBG1, RAB11A, CCDC88B, CCDC88A, SPAST, KIF19, KATNAL1, KPNB1, CLASP1, PAFAH1B1]
GO:0070933;histone H4 deacetylation;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;358.70493891627973;7.57984905034425;0.012005531492041683;0.8028748447945538;[HDAC1, SIRT7, SIRT2]
GO:0030950;establishment or maintenance of actin cytoskeleton polarity;6.0;1.0;0.8231203125901445;9.628524252492122;64.1120899346335;7.212124270218933;0.002145773952977257;0.6919486831672181;[RHOC, AQP1, RHOB]
GO:0070932;histone H3 deacetylation;10.0;0.8653626801206646;0.8479223519212526;9.510741216835738;358.70493891627973;6.781341354126479;0.012005531492041683;0.7620391240755716;[PER2, HDAC3, HDAC1, SIRT7, SIRT2]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[FANCI, TAOK2, DONSON, TOPBP1, CDK5RAP3]
GO:1903363;negative regulation of cellular protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.360260265897443;873.2316288148301;5.500407508664414;0.029226276758988614;0.6562910957882058;[PDCL3, RPS7, DERL3, CLEC16A, PBK, DERL2, PARK7, CDK5RAP3, UBAC2, MTM1]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[VPS29, AHCYL1, RPL3, NUP107, TFRC, ZDHHC6, RPS15, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, ARRDC1, COG4, COG3, AP1B1, ATG10, COG1, MYO7A, SCAMP1, SYTL3, SCAMP3, BCR, RUFY1, NUP93, DOPEY2, UNC50, KIF20A, RPL29, ACOT4, VPS26B, ABCB9, VPS8, VPS11, ATP6V0A2, SSR1, VPS16, BBS2, XBP1, PMM1, RAB3IP, PMM2, RAB27B, POLA2, NPLOC4, HYOU1, CD24, ARF3, ARF4, TRAM1, AHCTF1, SRP54, ARHGAP1, CLTA, MIA3, LYST, TRAM2, XPO5, KIF13B, TMED2, TMED1, TMED7, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, BTN3A2, COMMD1, RHOB, VAMP8, AFTPH, LSG1, GAL, AGPS, EXOC3, SLU7, VAMP5, PAFAH1B1, EXOC1, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, GGA3, SNX25, LMNA, AP2S1, HEATR3, STX5, CCL19, BID, RAE1, RPL19, PEX16, MON2, PEX19, AGK, SYVN1, SNX22, RAB11A, YIF1A, ARCN1, CENPF, SPCS2, SNX19, GPAM, SNX17, SNX14, TAOK2, RAB3GAP2, APBA3, RAB3B, SYS1, DGKD, NCF1, PDCD6, TBC1D3C, PARK7, IPO4, RAB43, RPH3A, EIF4ENIF1, IPO8, IPO9, LAMP2, RPS9, RPS7, VPS33A, VPS33B, TOMM34, TBC1D2B, RINT1, RAB35, CHMP4B, SLC27A2, KPNB1, PPID, CARD11, COPB2, COPA, SUCNR1, HSP90B1, MTM1, NCKIPSD, CLTCL1, NLRP3, ECT2, RAB6A, TBC1D15, ATP6V1F, AP1M1, TOR1A, VTA1, NUP153, TIMM44, NFKBIA, PAN3, CDK5, TMEM115, BCL3, SFT2D3, YWHAB, GPR89B, SEC61A2, AP1G2, AP1G1, NUP62, ITGAV, EVI5L, TNPO1, TNPO2, SNAP29, ARL5A, PDCD6IP, DTX3L, RHBDF2, FGG, TBC1D8, VPS13B, VPS37A, VPS37B, SENP2, ARFGAP1, ACOX2, LCP2, CHMP6, SEC22C, VPS4B, GOSR1, RRBP1, NLRC4, RAB21, AP3M1, RAB20, RAB40C, VPS52, VPS54, RAB28, TIMM8B, ARFGEF2, MX2, RPL23A, MCM3AP, VPS41, RAB13, RAB18, RUNDC1, VPS45, SEC24C]
GO:0009826;unidimensional cell growth;5.0;0.7763722522362496;0.6784271379790451;9.148951172230236;77.48500183936069;9.083926447120524;0.00259335327958913;0.7547934328124444;[BIN3]
GO:0046580;negative regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;288.24654468039586;5.885253329569843;0.009647352445404638;0.6972127541467594;[ITGB1, FLCN, NUP62, RAPGEF1, SPRY1, MET]
GO:0072740;cellular response to anisomycin;6.0;1.0;0.8231203125901445;9.628524252492122;162.42109747177753;9.777073627680469;0.005436087962882797;0.8231203125901445;[MAPK13]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[TOP2B, C12orf57, LRFN4, ALS2, CDK5, NFIB, RYK, TAOK2, OMG, NPTX1, NEFH, PAFAH1B1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[NCKAP1, OXTR, RPS6KA4, RPS6KA5, RPS6KA2, MYC, ARL6IP5, GTSE1, PDK1, PAQR3, BCR, NISCH, DEPDC1B, KARS, DDIT4, TRIB3, PAXIP1, CRHR1, ABR, NUAK1, RHOT2, RHOT1, RRAS, TP53BP2, STK38L, CCR10, SULT1A3, XBP1, SETDB1, EIF2AK3, RAB27B, SETX, CCDC88A, CYLD, COL1A2, CALM3, CALM1, RGL1, CD24, CALM2, BTG2, CDKN1A, CD40, ARHGAP1, BRCA1, BBC3, AKAP13, AKAP11, NKIRAS1, C1QBP, CTSH, HRAS, TEAD2, RAB8B, CCR2, DUSP5, MAP4K2, SPHK1, TMEM173, RHOC, GFRA2, SIRT2, VAV1, CIT, VAV2, RHOB, ITPKB, GAL, KIT, DEPDC1, RAPGEF1, TAX1BP3, ARHGEF1, TLR7, ARHGEF5, EXOC1, HBEGF, PTGER4, PCNA, GPS1, ADCY4, GPS2, TANK, RELA, PPP2CA, PERP, BID, MAP3K3, MAP3K1, CCL20, MYO9B, RAB11A, ITCH, CAMK4, TAOK2, CAMK1, TJP2, RAB3B, DGKD, RTKN, DGKA, CD80, SIRPG, IL5RA, DEFB1, PARK7, IGF1R, RAB43, DOCK11, ARHGDIB, CFL1, EP300, SNIP1, NEK1, IFNAR2, PDGFRB, USP8, IGFBP5, ERN1, RAB35, ELMO1, KPNB1, CARD11, DIABLO, CLEC16A, ITPR2, RASGRP2, STK4, KRCC1, RASGRP4, STK3, RAP1B, CCNB1, ZMAT1, TBXA2R, STK38, ABL1, DVL3, MBP, RIPK1, ECT2, RAB6A, MARK2, PRNP, IFT122, TNFRSF10B, CNOT10, NFKB1, NFKBIA, CNOT4, CNOT6, IRAK1BP1, CNOT7, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, NMUR1, CNOT8, LSM14A, BCAR3, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, TRADD, ATP2A2, PKD2, PIK3CG, POLB, FLCN, CASP3, CASP2, ITGAV, KSR1, OXSR1, MASTL, SPTB, TFDP1, ALS2, TFDP2, ADORA2A, PIK3C3, LCP2, LCP1, DOCK2, MET, ROCK2, TUFT1, RAB21, FZR1, GNG2, RAB20, PABPN1, RAB40C, CCL5, TIFA, MKNK2, NCAM1, ZNF622, RAB28, SH2B3, E2F7, E2F8, ARFGEF2, ANGPT1, TSHR, MAPK13, SNRK, P2RX4, TNIP2, ASB8, RAB13, RAB18, CCM2, KRAS, TEK, ASB3]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[KCNG1, KCNK6, SLC23A2, CLIC5, SLC25A3, COX4I1, SLC35B1, ARHGAP1, ATP2A2, PKD2L1, COX6A1, PKD2, BEST3, GPR89B, AQP1, CPT2, NNT, ARL6IP5, PMPCB, ITGAV, CLCC1, ATP7A, SLC30A7, SLC36A1, KCND1, SLC35C2, KCNK12, CACNA2D3, ZDHHC13, ATP1B2, HTR3B, ATP5F1, TRPC4AP, SLC39A14, SLC5A6, COX7A2L, SLC9A6, NDUFS7, SLC25A19, VDAC3, VDAC2, SLC25A10, XPR1, STOML2, SLC35D1, SLC20A1, COX15, KCNA3, ITPR2, ATP5J, ATP5I, SLC1A4, COX5B, ATP5O, CLCN3, ACACA, ATP5L, RHD, ANKH, ATP6V0A2, SLC38A6, CYC1, SLC25A20, CCL19, KCNN3, APOL1, SLC36A4, NTSR1, ATP6V1F, TIMM8B, SLC35A2, SLC12A2, SLC37A1, ATP13A1, SLC31A1, P2RX7, P2RX4, SFXN3, SFXN4, FXYD5, CALM1, KCNK3]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[PTGER4, SUCNR1, FCER1G, ITGA2, PARK7, PIK3CG, MAPK13, NFKBIA, C3, VAMP8, NLRP12, IL6, KARS, IL23A, NPPA, TLR7, CCR2]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[DIABLO, ARL6IP5, ZNF622, PDK1]
GO:1903936;cellular response to sodium arsenite;6.0;1.0;0.8231203125901445;9.628524252492122;318.4741730750533;8.16763571524637;0.010659043964674443;0.7408135829017477;[MAPK13]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[PTGER4, MTPN, NCKAP1, GMFB, WDR1, ROCK2, WIPF2, ARPC1A, WASL, IQGAP2, CORO1A, AKAP13, BAG4, ARHGDIB, CFL1, PPFIA1, ABL1, NCKAP1L, ARFIP1, HRAS, CLASP1, S100A10, VASP, PDGFRB, ACTR2, SWAP70, RHOC, SSH3, SPTB, CIT, RHOB, VIL1, CCDC88A, SFRP1, ARPC2, CDK5, FES, TAOK2, TEK, EPHA1, MET, ARHGEF5]
GO:0002769;natural killer cell inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;9.083926447120524;0.004356384815420379;0.839552420951524;[CLEC12B]
GO:0015718;monocarboxylic acid transport;8.0;0.5640623033008358;0.6570311516504179;7.75672207559053;50.19664702939052;4.879233827729558;0.0016800366020243219;0.6245242448576669;[PLA2G12A, ABCC2, ABCD3, ABCB4, STARD10, ACACA, SLC16A14, SLC5A6, RXRA, CPT2, SLC16A6, SLC25A20, SLC27A2, SLC16A5]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[MARCKS, SWAP70, NEDD9, LCP1, RHOC, HSP90B1, RHOB]
GO:0007072;positive regulation of transcription involved in exit from mitosis;11.0;0.8653626801206646;0.8651102923899945;9.55056271102241;1226.7078670235967;9.777073627680469;0.04105680834387496;0.9324289523296623;[SIRT7]
GO:0007193;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.117698628726131;28.36322711391944;5.334422371190153;9.492916862557204E-4;0.6478026081386739;[RIC8A, RGS1, ADCY4]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[DUSP5, CAV1, GPS1, PAQR3, GPS2, PTPN22, DUSP14, PPP2CA, DUSP22, SFRP1, NUP62, STK38, SPRY1, CDK5RAP3]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, PAXIP1, MAX, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, CHD8, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, FLCN, NIPBL, SIN3A, HRAS, TEAD2, ZNF485, KLF13, RBM15, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, GPS2, RELA, ARNTL, RXRA, PLAGL2, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, KLF6, NFIA, NFIB, TNIP2, TTC5, NFIC, PSMC1, ASXL2, TAF7, CAMK1, TAF4, MIXL1]
GO:1901888;regulation of cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.318252308649967;5.370354380416217;9.14317319939619E-4;0.5648811846224242;[RAP1B, SFRP1, ROCK2, CAV1, RCC2, ABL1, RAPGEF1, TEK, THBS1, CLASP1, LIMS1, S100A10]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[DDX17, PAQR6, EGLN2, NCOA6, WBP2, RORA, UBE3A, BRCA1, SAFB, ARID1A, PIAS2, RXRA, MED30, CCNE1, UBR5, TAF7, FKBP4]
GO:0018094;protein polyglycylation;9.0;1.0;0.896240625180289;9.628524252492122;157.24152745118337;8.390779266560578;0.005262732415603891;0.8253454670833372;[TTLL3]
GO:0014839;myoblast migration involved in skeletal muscle regeneration;7.0;1.0;0.8509193652572005;9.628524252492122;22.014357120524497;9.083926447120524;7.368007211888268E-4;0.8154717862087246;[BIN3]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, IGFBP5, IL12A, COMT, SF1]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[DDX17, MED30, CCNE1, UBE3A, BRCA1, ARID1A, FKBP4, PIAS2]
GO:0030520;intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;6.7325511899570465;0.0018077141342769656;0.719302980950052;[DDX17, EGLN2, NCOA6, TAF7, SAFB, ARID1A]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[MAP3K3, SCARB1, GPI, CD40, BMPR2, ANGPT1, ROCK2, ITGB3, PDCD6, CIB1, THBS1, RHOB, P2RX4, SP1, ABL1, TEK, MET]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[BECN1, GABARAPL1, CALCOCO2, VTA1, EI24, VPS4B, ATG10, VPS37A, VPS37B, DYNLL2, PRKAB1, CLN3, FUNDC1, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6, ATG5]
GO:0051028;mRNA transport;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;42.48893056556077;4.77312732173501;0.0014220662684744023;0.6190979532066485;[AHCTF1, SMG1, SEH1L, NUP107, POLDIP3, EIF4A3, CASC3, SUPT6H, SMG5, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, NUP43, RAE1, UPF2, UPF1, SEC13, CPSF3, MX2, CPSF2, NUP153, THOC2, SENP2, SRRM1, THOC6, NUP93, MCM3AP, SLU7]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[BECN1, USP36, USP37, WDR48, USP38, USP32, USP12, USP34, OTUD7B, NEDD8, BRCA1, USP39, PSMB10, PSMA7, YY1, PSMD8, POLB, VCPIP1, TFPT, RHOT1, PSMD7, PSMB5, PSMD4, PSMD2, MYC, PSMB1, NLRP3, USP51, RIPK1, SKP2, USP46, USP8, RAD23A, JOSD1, CDC25A, NFKBIA, CYLD, COPS5, PSMA1, TNIP2, PSMC1, ASXL2, PSME2, USP41]
GO:1905451;positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis;9.0;1.0;0.896240625180289;9.628524252492122;644.8897711089396;9.083926447120524;0.021583880275902575;0.8607930461318132;[RAPGEF1]
GO:0048545;response to steroid hormone;5.0;0.6913464685778243;0.6359142461498324;8.935377071932177;60.25199573142884;4.388001897863968;0.0020165800738552384;0.51464363298064;[ERRFI1, OXTR, CDKN1A, PCNA, WBP2, ABCB4, UBE3A, THBS1, RELA, UBE2L3, AQP1, CASP3, RBBP7, USP8, PAQR6, ABCC2, ABCA3, CAV1, SERPINF1, CAD, SOX30, IL6, DDIT4, SDC1, KRAS]
GO:0090160;Golgi to lysosome transport;8.0;1.0;0.875;9.628524252492122;114.4124755644324;7.697632086000634;0.0038292825925985686;0.7686572628545723;[GAK, AP1G1, ANKFY1]
GO:0045953;negative regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.6560499367194;7.379178354882098;0.014447139526158352;0.7736121494158466;[CLEC12B, HAVCR2]
GO:0042325;regulation of phosphorylation;7.0;0.468531447706225;0.585185089110313;6.879652056869657;31.28210038194581;2.461190123170684;0.001046983747721169;0.4767847426131948;[ERRFI1, CCNK, GMFB, NCF1, CCNH, CD80, CCNF, CIB1, PARK7, IGF1R, RPS6KA4, RPS6KA5, MYC, ARL6IP5, NEK1, IL12A, EPHB4, CDK5RAP3, PDGFRB, FBXO18, PAQR3, FLT3LG, VRK2, MAPK8IP3, CDC25A, ERN1, COX7A2L, SFRP1, TWSG1, KARS, CCNE2, IL23A, CCNE1, DDIT4, MADD, PPIF, JTB, MTCP1, TRIB3, ADNP, EPHA1, PKMYT1, STK4, AGER, STK3, IL22RA2, C3, RAP1B, CCNB1, BAG4, HSPH1, RRAS, PRDX1, STK38, ABL1, DVL3, NCKAP1L, RIPK1, ECT2, FAM83D, MARK2, PRNP, XRCC6, UBE2B, AMBP, XRCC5, CAV1, GLMN, EIF2AK3, TNFRSF10B, TNFRSF10A, PILRB, CDK9, CCDC88A, IL6, COPS5, CDK6, CNOT7, EHD4, CDK5, ARL2BP, QARS, GNAQ, PKIA, FGFR1OP, CALM3, CRIPAK, CALM1, MNAT1, CD24, CALM2, CCNJL, EZH2, CDKN1C, BCAR3, CDKN1A, CD40, BMPR2, ITGB3, ITGB2, KIF14, PTPN22, LDB2, PKD2, PIK3CG, DUSP14, CKS1B, FLCN, AKAP13, NNT, CASP3, NUP62, PBK, ITGAV, ATP7A, HRAS, DACT1, HAVCR2, FGA, DUSP5, MAP4K2, KSR1, SPHK1, FCRL3, FGG, PLAUR, ZFP91, ARNT, PPP2R5D, OXSR1, SENP2, GFRA2, SIRT2, VAV2, ITPKB, DUSP22, NCOR1, RBL1, ALS2, ADORA2A, CTDSP2, KIT, RAPGEF1, LCP2, MAPRE3, TLR7, CHMP6, MET, ARHGEF5, PAFAH1B1, HBEGF, MCPH1, VAC14, HDAC3, ROCK2, GPS1, ITLN1, GPS2, LRP8, THBS1, PPP2CA, KCTD20, SNX25, CCL5, CSK, ZNF622, CCL19, TBX1, MAP3K3, PPP1R14B, CDKN2C, MAP3K1, PDE6H, ANGPT1, SEMA4D, CCL20, RYK, GPR55, P2RX7, CENPE, PDCL3, ITCH, CD4, NLRP12, PIK3IP1, TAOK2, TAF7, CDK2AP1, KRAS, SPRY1, CAMK1, TEK]
GO:0048549;positive regulation of pinocytosis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;174.47961519612048;8.390779266560578;0.005839675699155172;0.8041048419030481;[ANKFY1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TBX1, FXR1, CENPF, XBP1, MEF2B, SOX6, VAMP5, EMD, HBEGF]
GO:0071787;endoplasmic reticulum tubular network formation;6.0;1.0;0.8231203125901445;9.628524252492122;40.015776953454136;8.390779266560578;0.0013392920427709397;0.7522251544931926;[RTN3]
GO:0031047;gene silencing by RNA;8.0;0.7671156992804218;0.7585578496402109;9.168991923113682;70.59795582467933;5.885253329569843;0.002362850047416754;0.6759721289664703;[DDX17, CNOT6, CNOT7, CNOT1, CNOT3, CNOT10, HELZ, CNOT8, SND1, TNRC6A]
GO:0010921;regulation of phosphatase activity;8.0;0.6493065804076676;0.6996532902038338;8.679443697794976;45.363813980682416;4.61801832846594;0.0015182860291514271;0.6111656720775624;[ELL, PPP1R11, ROCK2, PPP2R2A, PKMYT1, HSP90B1, NUAK1, BAG4, PPME1, PPP1R7, PHACTR2, NCKAP1L, CDK5RAP3, PDGFRB, PPP1R14B, SEMA4D, ITGA2, FCRL3, PPP2R5D, MASTL, MYO1D, NSFL1C, RCAN3, CD2BP2, CALM3, CALM1, CALM2]
GO:0072709;cellular response to sorbitol;6.0;1.0;0.8231203125901445;9.628524252492122;152.1977355403849;8.67846133901236;0.005093921239467482;0.7669372290569613;[MAPK13]
GO:0003091;renal water homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;57.14336741787613;6.311337724880743;0.0019125370817844765;0.6736814700148209;[WFS1, ADCY4, AQP3, RAB11A, AQP1]
GO:0045445;myoblast differentiation;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;6.599019797332524;7.050676185779127E-4;0.587474179321389;[DDX17, MBNL1, MAML1]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[TCERG1, ZNF175, CCNK, CCNH, ZNF292, ARID4A, ELK1, MYC, TRIM24, EP300, IER2, GTF2I, MEF2B, ZBTB32, RFX4, MAX, RPAP1, SUPT6H, GTF2E2, RAD21, HLTF, HIVEP1, HOXC4, ZBED1, HIVEP2, TFAP2A, ZBTB17, ZNF143, XBP1, INTS3, PBX3, EAF2, NFXL1, FLI1, NFKB1, CDK9, STAG1, TFCP2, COPS5, SP1, MAFF, NFE2L3, INTS4, INTS7, INTS6, MNAT1, ZNF136, INTS8, NFE2L1, BMPR2, ONECUT2, ELL, INTS10, HOXC13, BRCA1, AFF4, ZNF768, KLF11, TBP, KLF13, MKL1, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, TFEC, MED20, ZNF516, LCOR, WBP2, CEBPG, RELA, ARNTL, POLR2B, TAF1A, POLR2E, PLAGL2, POLR2G, TCFL5, POLR2J3, NFYC, ARID3B, DEK, GRHL1, USF2, GTF2H4, GFI1B, KLF6, NFIA, NFIB, NFIC, TAF7, TAF5, TAF4, MIXL1]
GO:0007210;serotonin receptor signaling pathway;5.0;0.8259837884571596;0.7032329060895001;9.117698628726131;23.17027026302992;6.343086423195323;7.75488093814194E-4;0.6146267465268138;[HTR3B]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[DDX17, RPS9, WDR37, DDX27, RPS7, POP4, SUV39H1, WDR18, EIF4A3, HEATR1, ISG20L2, NOLC1, NAT10, IMP4, WDR43, BYSL, RRP9, RPS15, BOP1, LAS1L, RPL7L1, PES1, MRTO4, EXOSC3]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[GPI, CRTC2, TPI1, IGFBP5, ADPGK, DCXR, BPGM, PER2, NISCH, HK3, G6PC3, ALDH5A1, FABP5, SLC25A10, ALDOC, ALDOA, PDK1]
GO:0000381;regulation of alternative mRNA splicing, via spliceosome;10.0;1.0;0.9152410118609203;9.628524252492122;185.80693659341267;5.649939242635378;0.00621879095239513;0.704179167478338;[DDX17, PTBP1, MBNL1, WTAP, SAP18, RBM5]
GO:0000380;alternative mRNA splicing, via spliceosome;12.0;0.9326813400603323;0.9144609826203107;9.584072489921288;357.76734256588776;7.004484905440688;0.011974150985975996;0.8063299963962409;[DDX17, SLU7]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[ACTR2, TMEM30A, BMPR2, SEMA4D, TNFRSF12A, SERPINF1, TRAK1, LRP8, RAB11A, NME1, RAB21, SETX, NCKIPSD, FES, RUFY3, CAPRIN1, RAPGEF1, DVL3, CAMK1, ADNP, SCARF1, MARK2, PAFAH1B1, EZH2]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[HDAC3, DTX3L, JUP, BAG3, TPR, UBR5, EIF2AK3, PARK7, ECT2, TMEM173, GTSE1, CDK5RAP3]
GO:0006493;protein O-linked glycosylation;8.0;0.7140352122741334;0.7320176061370667;9.022388448921806;176.5615275388073;5.085725745451326;0.005909355431665436;0.6350842511328143;[GALNT12, GALNT11, MGEA5, DPM3, ST6GAL1, SDF2L1, SLC35C2, GALNT1, SLC35C1, PGM3, TRAK1, GALNT10]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[BBS2, SPAG16, ACTR2, GALNT11, SEPT11, ONECUT2, IFT122, FNBP1L, WDR34, DYNLL2, SEPT2, TTLL3, TMEM138, RFX4, CENPJ, TMEM107, NEK1, CCDC65, SNAP29, CLUAP1]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[NFKBIA, CYLD, ITCH, NLRP12, BRMS1, ADORA3, GFI1, NLRP2, NLRP3, COMMD1, CDK5RAP3, HAVCR2]
GO:0006497;protein lipidation;7.0;0.6519675769143192;0.6769031537143602;8.673012807464685;151.15475272427284;5.382624473008031;0.005059013543235805;0.6261870311244675;[DPM3, PIGU, PIGA, ZDHHC23, ZDHHC5, ATG10, ZDHHC24, ZDHHC6, PIK3C3, ATG5]
GO:0007224;smoothened signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;5.528578385631111;8.87013979980389E-4;0.6058520683365068;[NSDHL, CENPJ, IFT122, PKD2L1, SEPT2]
GO:0000389;mRNA 3'-splice site recognition;8.0;0.9326813400603323;0.8413406700301662;9.541512875502493;67.28910983118142;7.9853141584524145;0.0022521059497824397;0.7833693374183408;[SLU7, SF1]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[RAPGEF1, CORO1A]
GO:0000266;mitochondrial fission;5.0;1.0;0.7902410118609202;9.628524252492122;40.48578058269761;6.686031174322154;0.0013550226412659145;0.6321649570480018;[MX2]
GO:0002687;positive regulation of leukocyte migration;8.0;0.6634067003016617;0.7067033501508309;8.963547948898873;238.70113796770806;4.956792062075433;0.007989112270702124;0.6284905765689417;[CXCL6, CCL20, DOCK8, ITGA2, SWAP70, CD99L2, MIA3, THBS1, CXCL14, CREB3, IL6, KARS, IL23A, C1QBP, CCL5, NCKAP1L, IL12A, CCL19, CCR2]
GO:0032515;negative regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1090.4524045737035;5.788089581116195;0.03649646063763195;0.7112441822128948;[PPP1R14B, PPP1R11, ROCK2, PPME1, PHACTR2, NCKAP1L, MASTL]
GO:0003417;growth plate cartilage development;6.0;1.0;0.8231203125901445;9.628524252492122;33.90475965706645;8.16763571524637;0.001134761793419349;0.7408135829017477;[THBS3]
GO:0010501;RNA secondary structure unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;115.0816327851482;5.948432231191374;0.0038516786825735262;0.6551224661907153;[DDX17, DDX59, DDX27, EIF4A3, DDX23, DDX42, DDX41]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[P2RX7, IL23A, HLA-C, IL12A, HLA-A, HLA-F, IL12RB1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, MAST3, ROCK2, STK4, RPS6KA4, CCNB1, RPS6KA5, STK38, MKNK2, STK38L, RIPK1, MARK2, EIF2AK3, CDC7, VRK1, VRK2, MASTL, MAPK13, CLK1, ERN1, CDK5, CAMK4, CDK2, CAMK1, CSNK1G2, CSNK1G1]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[P2RX7, IL6, XBP1, FCER1G, ZBTB20, MBP, TLR7, TBC1D23, MAPK13]
GO:0030575;nuclear body organization;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;20.915744831851537;7.379178354882098;7.000311565738116E-4;0.6676125360964777;[SF1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[PTGER4, MCTP1, MIA3, WASL, PTPRK, THBS1, ABR, FLCN, RRAS, TBXA2R, ADORA3, TP53INP1, ARHGDIB, CLASP1, RNF20, STARD13, IGFBP5, JUP, SERPINF1, IDH2, RHOB, BCR, NISCH, SFRP1, EPHA1]
GO:0000917;division septum assembly;5.0;1.0;0.7902410118609202;9.628524252492122;64.8471400300091;9.777073627680469;0.002170375418167341;0.7902410118609202;[BIN3]
GO:0090114;COPII-coated vesicle budding;7.0;1.0;0.8509193652572005;9.628524252492122;41.05829977546847;7.9853141584524145;0.0013741843434141336;0.7592887026755414;[SEC13, VAPA]
GO:0061154;endothelial tube morphogenesis;6.0;0.8259837884571596;0.7361122068187242;9.310070521373587;48.80114014223953;7.379178354882098;0.0016333302423860384;0.7004918368257019;[STARD13, CCM2, RHOB]
GO:0090110;cargo loading into COPII-coated vesicle;7.0;1.0;0.8509193652572005;9.628524252492122;99.46684456500904;7.212124270218933;0.0033290657732425078;0.7197477358342742;[SEC13, TBC1D20, MIA3, SEC24C]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, CCNK, GMFB, MAML1, CCNH, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, RPS6KA5, RPS6KA2, MYC, CFL1, TRIM24, NEK1, EPHB4, PDK1, PDGFRB, CSNK2A1, PAQR3, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, TRIB3, EPHA1, CSNK1G2, CSNK1G1, PKMYT1, STK4, RASGRP4, STK3, NUAK1, CCNB1, STK35, STK38, ABL1, STK38L, MBP, RIPK1, MARK2, SULT1A3, EIF2AK3, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, FGFR1OP, CALM1, MNAT1, SMG1, BMPR2, FASTKD1, MAST3, YWHAB, PIK3CG, AKAP13, ZMYM2, PBK, CTSH, ITGAV, HRAS, DUSP5, MAP4K2, KSR1, CAD, OXSR1, MASTL, GFRA2, SPTB, CIT, GAK, ITPKB, PDIK1L, KIT, FASTKD5, PIK3C3, TLR7, BIRC6, MET, HBEGF, PTGER4, ROCK2, GPS1, GPS2, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, MAP3K1, ANGPT1, GTF2H4, MAPK13, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, CAMK1, TEK]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, ZBTB20, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, THAP1, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, CBX4, WFS1, BCL11A, CAV1, NFXL1, NFKB1, CNOT7, YEATS2, CNOT1, PKIA, SP3, CDK2, NFE2L3, RCOR3, ZNF136, EZH2, CIITA, BTG2, TCF25, SUV39H1, CHD8, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF11, HBZ, KLF12, PEG3, RFC1, SIRT7, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7, TRIM33]
GO:0048741;skeletal muscle fiber development;7.0;1.0;0.8509193652572005;9.628524252492122;69.27622651621293;6.558197802812269;0.0023186129569415337;0.6863059058804069;[BIN3]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, CSTB, CSTA, ITIH2, SERPINA10, NLRC4, PARK7, UBE2Z, THBS1, AQP1, C3, BCL2L12, NLRP7, RFFL, A2M, SERPINB1, CSNK2A1, AMBP, SERPINF1, PLAUR, TNFRSF10B, TNFRSF10A, SERPINB6, VIL1, ADORA2A, COL7A1, BIRC6]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[BECN1, PCNA, PARK7, RELA, AQP1, RHOB, MAPK13, SETX, IL6, PPIF, ABL1, ECT2, EZH2]
GO:0050810;regulation of steroid biosynthetic process;7.0;0.6073376606709605;0.6545881955926808;8.270400768338927;49.64364795809466;5.370354380416217;0.0016615282207749023;0.6255595380187045;[GGPS1, NFYC, GFI1, ELOVL6, ERLIN2, NFKB1, ACACA, SQLE, GPAM, SP1, SCAP, KPNB1, SF1]
GO:0044829;positive regulation by host of viral genome replication;9.0;1.0;0.896240625180289;9.628524252492122;209.9603317012029;7.8311634786251565;0.0070271833500085345;0.7967266896635242;[TBC1D20, VAPA]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNK, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, SND1, THAP1, EID1, EWSR1, RFX4, HOXB4, TRIB3, ASF1B, SF1, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MYCBP2, ZNF20, CDCA7, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, INTS6, RCOR3, ZNF136, INTS8, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ING2, ZMYM2, SCML1, C1QBP, CIC, JARID2, ZNF485, BRD3, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, SIRT7, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, HEATR1, GPS2, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, PLAGL2, GPBP1L1, ZNF101, ZNF462, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, ZBTB20, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, CBX4, NONO, NFXL1, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, TMEM18, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, PHTF2, CIITA, BMPR2, ONECUT2, CHD9, CHD8, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, ZNF516, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2E, SAP18, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TCFL5, TBX1, POLR2J3, SPEN, CHURC1, EYA2, ARID3B, DEK, USF2, MAPK13, KLF6, POLR3B, POLR3C, TNIP2, POLR3E, ASXL2, TAF7, MNDA, TAF5, TAF4, TRIM33]
GO:0044828;negative regulation by host of viral genome replication;9.0;1.0;0.896240625180289;9.628524252492122;287.7494343559507;8.16763571524637;0.009630714610215706;0.8139338954918922;[CCNK, VAPA]
GO:0044387;negative regulation of protein kinase activity by regulation of protein phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1099.13927172128;7.697632086000634;0.03678720226338847;0.8260862151842345;[CDK5RAP3]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[ZNF175, NUP107, MAML1, ZNF292, GPATCH3, ELK1, MYC, ZXDC, IER5, IER2, CDK5RAP3, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, HCFC2, SND1, MED6, RC3H2, EID1, EWSR1, RFX4, HOXB4, ASF1B, SF1, ZNF276, ZNF395, ZNF274, ZNF394, MEPCE, ZNF20, CDCA7, NOLC1, ZNF25, MTDH, HSPH1, RAD21, HESX1, HOXC4, ZNF264, ZNF143, CREBBP, ZNF263, JUP, ZNF260, H3F3A, PBX3, EIF2AK3, ERLIN2, ZNF35, FLI1, SOX30, SETX, CYLD, QARS, PKIA, ZNF30, ZNF136, EZH2, CDKN1C, SETD5, ARF4, BTG2, CDKN1A, SETD3, BTG1, ELL, ZNF250, TCF25, ATF7IP2, HOXC13, ZNF45, WDR43, NIPBL, CHAF1B, ING2, CIC, JARID2, TEAD2, HAVCR2, ZNF485, BRD3, HELLS, SPHK1, BAZ1A, SIRT7, TMEM173, MED29, SIRT2, MED28, GNL3, NCOR2, NCOR1, MTF2, MED20, ZNF350, GPS2, ZNF69, BCLAF1, UBN1, PLAGL2, ZNF101, ZNF462, EGLN2, ZNF581, ATAD2, GTF2H4, CENPF, NFIA, NFIB, NFIC, PSMC1, ZNF696, MIXL1, ZNF212, LIMS1, ZNF331, NCF1, NAB1, GMNN, UBP1, ZBTB20, RORA, YEATS4, PARK7, YY1, ADORA3, ZNF207, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, ILF3, ADNP, ZNF550, MAX, RLF, GTF2E2, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, DVL3, ZNF544, TRAPPC2, ZBTB17, DR1, WFS1, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CDK5, YEATS2, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, CIITA, BMPR2, ONECUT2, TRADD, ITGB2, LBH, SIN3A, ZNF407, ZNF768, ZNF525, ZNF524, ZNF766, HIF1AN, PEG3, DTX3L, RFC1, ZFP91, ARNT, ZFP90, DUSP22, TFDP1, ZNF519, TFDP2, ADORA2A, ZNF516, LCOR, ZNF511, MET, ZNF630, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, NLRC4, LRP8, RBBP5, DNAJB5, TP53INP2, TP53INP1, SAP18, ASCC3, ZNF622, RBBP7, E2F7, E2F8, IRX1, TBX1, RNF20, SEMA4D, FBXL15, KLF6, POLR3C, ASXL2, MNDA, TRIM32, TRIM33, TCERG1, CCNK, CCNH, GFI1, IKZF1, IKZF2, UBE2L3, TIAL1, RPS6KA4, RPS6KA5, SAP130, DPF2, TRIM24, SOX8, FBXO5, SOX6, SFMBT2, FLT3LG, RUNX2, THAP1, THAP6, SFRP1, TWSG1, KARS, IL23A, BOLA3, TRIM14, TRIB3, ANKRA2, PAXIP1, FOXG1, MYCBP2, GMCL1, COMMD9, HLTF, HIVEP1, SCAP, ZBED1, HIVEP2, XBP1, XRCC6, SETDB1, XRCC5, BCL11A, EAF2, STAG1, GOLGB1, RCOR3, AHCTF1, CD40, SUV39H1, OTUD7B, BRCA1, WASL, PTPRK, AATF, ZMYM2, SCML1, C1QBP, HRAS, TSC22D4, HBZ, SEC13, NCOA6, PRMT3, TSC22D2, COMMD3, COMMD1, PPRC1, ZFX, VAV1, TOX4, GAL, NFX1, CSDE1, TFEC, KIT, DEPDC1, MAPRE3, VGLL4, ARHGEF5, PCNA, HEATR1, NEDD8, ZNF2, TRAK1, RELA, ARNTL, PPP2CA, SERTAD3, RXRA, SERTAD2, TCEAL3, GPBP1L1, SCAND1, APBB3, NFYC, GRHL1, PER2, ITCH, NLRP12, GFI1B, HIST3H2A, TTC5, CAMK4, MARS, CAMK1, CRTC2, CD80, ARID4A, CIB1, UBE3A, WWC3, EP300, SNIP1, SSU72, ERN1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, PPID, CARD11, SUPT6H, AGER, STK3, NLRP2, NLRP3, RIPK1, CYTL1, SUDS3, BPTF, TFAP2A, PRNP, UBE2I, CBX4, NONO, CAV1, NFXL1, CNOT10, NFKBIA, IL6, ZSCAN2, PHF19, USP36, PHTF2, YWHAB, CHD9, CHD8, DDX41, LDB2, PKD2, CHD1, AFF4, CKS1B, FLCN, NUP62, GATAD1, LRRFIP1, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, BUD31, MKL1, SENP2, SAFB, ARID1A, CREB3, RBL1, SETBP1, ELF4, IRF4, EAPP, ITGB3BP, MCPH1, TFPT, FAM120B, TAF1A, MTA2, ZNF189, TCFL5, SPEN, CHURC1, EYA2, ARID3B, DEK, USF2, MAPK13, CD4, TNIP2, TAF7, KRAS, TAF5, TAF4]
GO:0046326;positive regulation of glucose import;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.68372616907679;5.970411137910149;0.0028342881044734467;0.6803271032452366;[CLTCL1, ITLN1, ADIPOR2]
GO:0000921;septin ring assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.16030555582066;7.069023426578259;0.003586558988939603;0.7124295520356204;[SEPT11, SEPT2]
GO:0061028;establishment of endothelial barrier;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;35.449043474319204;6.641579411751319;0.0011864475830175945;0.6627709925721352;[RAP1B, RAPGEF1, TJP2]
GO:0000245;spliceosomal complex assembly;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;66.59596265062147;6.444869117505266;0.002228906937441061;0.6805102716434839;[SNRPG, USP39, SF3B1, RBM5, SF1]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, SOX8, SOX6, IER5, IER2, CDK5RAP3, DDX17, ZNF18, MEF2B, ZNF282, FLT3LG, RFX1, ZNF12, HCFC2, MED6, RUNX2, RC3H2, THAP1, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, TRIB3, ANKRA2, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MEPCE, ZNF20, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, JUP, ZNF260, BCL11A, PBX3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, RCOR3, ZNF136, EZH2, ARF4, AHCTF1, BTG2, CDKN1A, CD40, SETD3, ELL, ZNF250, TCF25, SUV39H1, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, NIPBL, ZMYM2, C1QBP, CIC, JARID2, HRAS, TEAD2, HAVCR2, ZNF485, BRD3, TSC22D4, HBZ, NCOA6, TSC22D2, SIRT7, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, ZNF350, GPS2, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, RXRA, TCEAL3, UBN1, PLAGL2, ZNF101, ZNF462, EGLN2, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, ARID4A, UBP1, ZBTB20, RORA, YEATS4, UBE3A, PARK7, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TFAP2A, ZBTB17, DR1, UBE2I, CBX4, WFS1, NONO, CAV1, NFXL1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, YEATS2, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, CIITA, BMPR2, ONECUT2, CHD8, DDX41, LDB2, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PEG3, RFC1, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, ZNF516, LCOR, ZNF511, EAPP, MET, MCPH1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, LRP8, DNAJB5, SAP18, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, TBX1, SPEN, SEMA4D, FBXL15, ARID3B, DEK, USF2, KLF6, TNIP2, ASXL2, TAF7, TAF4, TRIM33]
GO:0046328;regulation of JNK cascade;11.0;0.7866048967936545;0.8257314007264895;9.485423408851448;236.19920713085625;4.6122876537569555;0.00790537489718426;0.6683015574361036;[HDAC3, NCF1, GPS2, PTPN22, AGER, STK3, IGF1R, DVL3, RIPK1, ZNF622, CCL19, HRAS, DACT1, MAP4K2, AMBP, MAPK8IP3, ERN1, DUSP22, ITCH, SFRP1, COPS5, NCOR1, TAOK2, RAPGEF1, ARHGEF5, PAFAH1B1]
GO:0098887;neurotransmitter receptor transport, endosome to postsynaptic membrane;14.0;1.0;0.9759193652572005;9.628524252492122;916.754991217747;7.9853141584524145;0.030682964530131116;0.8842887026755413;[GRIPAP1, RAB11A]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, ITGB1, CD40, BTG1, YWHAB, PDCD6, TRADD, PARK7, UBE2Z, BBC3, FLCN, AKAP13, RPS6KA2, C1QBP, MYC, CASP3, ARL6IP5, CASP2, CTSH, CTLA4, IL12A, RBM5, PDGFRB, KLF11, DFFA, C3orf38, ENDOG, FBXO18, RPS7, TNFRSF12A, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, VAV2, RHOB, SFRP1, GAL, BRMS1, TFDP1, TFDP2, ADORA2A, PTRH2, PPIF, ARHGEF1, ARHGEF5, ITGB3BP, PPID, DIABLO, NLRC4, STK4, THBS1, STK3, ABR, BCLAF1, CCL5, UBD, TP53INP1, TP53BP2, NLRP2, ABL1, NLRP3, SAP18, PLAGL2, RIPK1, SUDS3, ZNF622, ECT2, BID, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, G0S2, TNFRSF10B, TNFRSF10A, HSPE1, EIF2S1, P2RX7, CYLD, NLRP12, IL6, FAP, CDK5, MNDA, PDCD1, SERINC3]
GO:0031401;positive regulation of protein modification process;8.0;0.5146692605283323;0.6323346302641661;7.862082591248357;366.05417831255403;2.7148819953939136;0.012251503920748938;0.5138391914993687;[CCNK, NCF1, CCNH, CD80, PDCD6, CIB1, UBE3A, PARK7, UBE2L3, IGF1R, RPS6KA4, RPS6KA5, ARL6IP5, NEK1, IL12A, SKP2, EPHB4, CDK5RAP3, PDGFRB, FBXO18, ATG10, FLT3LG, MAPK8IP3, RNF40, ERN1, TWSG1, BRMS1, KARS, IL23A, MADD, JTB, MTCP1, TRIB3, ADNP, EPHA1, CDCA2, PAXIP1, STK4, AGER, STK3, C3, RAP1B, CCNB1, BAG4, HSPH1, ABL1, DVL3, NCKAP1L, RIPK1, ECT2, MARK2, FANCI, PRNP, XRCC6, UBE2I, XRCC5, WFS1, CAV1, TNFRSF10B, TNFRSF10A, PILRB, CDK9, CCDC88A, IL6, EHD4, CDK5, ARL2BP, CALM3, CALM1, MNAT1, CD24, CALM2, EZH2, PHF19, BCAR3, CDKN1A, CD40, WDR48, BMPR2, ITGB3, KIF14, PTPN22, BRCA1, PKD2, PIK3CG, CKS1B, FLCN, AKAP13, PTBP1, NIPBL, ING2, ITGAV, JARID2, HRAS, HAVCR2, FGA, DUSP5, MAP4K2, KSR1, SPHK1, FCRL3, FGG, PLAUR, ZFP91, ARNT, PPP2R5D, OXSR1, COMMD1, SENP2, MASTL, GFRA2, GNL3, DUSP22, ALS2, MTF2, KIT, RAPGEF1, LCP2, MAPRE3, MET, ARHGEF5, HBEGF, HDAC3, WBP2, ROCK2, ITLN1, LRP8, THBS1, TANK, ARNTL, PPP2CA, FZR1, PPP1R7, CCL5, UBQLN1, CSK, ZNF622, CCL19, TBX1, RNF20, MAP3K3, MAP3K1, PDE6H, ANGPT1, SEMA4D, CCL20, RYK, GPR55, P2RX7, CENPE, CD4, TAOK2, CDK2AP1, RAB3GAP2, KRAS, CAMK1, TEK, RAB3GAP1]
